A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Restasis Indications, Dosage, Storage, Stability - Cyclosporine
Restasis Indications, Dosage, Storage, Stability - Cyclosporine
INDICATIONS AND USAGE
RESTASIS™ ophthalmic emulsion is indicated to increase
tear production in patients whose tear production is presumed to be suppressed
due to ocular inflammation associated with keratoconjunctivitis sicca. Increased
tear production was not seen in patients currently taking topical anti-inflammatory
drugs or using punctal plugs.
DOSAGE AND ADMINISTRATION
Invert the unit dose vial a few times to obtain a uniform,
white, opaque emulsion before using. Instill one drop of RESTASIS™ ophthalmic
emulsion twice a day in each eye approximately 12 hours apart. RESTASIS™
can be used concomitantly with artificial tears, allowing a 15 minute interval
between products. Discard vial immediately after use.
HOW SUPPLIED
RESTASIS™ ophthalmic emulsion is packaged in single use
vials. Each vial contains 0.4 mL fill in a 0.9mL LDPE vial; 32 vials are packaged
in a polypropylene tray with an aluminum peelable lid.
RESTASIS™ 32 Vials 0.4 mL each-NDC 0023-9163-32
Storage: Store RESTASIS™ ophthalmic emulsion at 15°to
25°C (59°to 77°F). KEEP OUT OF THE REACH OF CHILDREN.
©2003 Allergan, Inc. Irvine, CA 92612,
U.S.A., ® and ™ Marks owned by Allergan, Inc.
US PAT 4,649,047; 4,839,342; 5,474,979.
Updated Nov 25, 2003.
top
